Preimplantation Genetic Testing Market Size, Share, and Growth Analysis, By Test Type, By Technology, By Category, By End-User, By Region - Industry Forecast 2025-2032

Global Preimplantation Genetic Testing Market size was valued at USD 877.5 million in 2023 and is poised to grow from USD 943.31 million in 2024 to USD 1682.38 million by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

Market insights indicate that the demand for preimplantation genetic testing is significantly driven by the increasing prevalence of genetic disorders, the rising rates of infertility, and advancements in genetic screening technologies, alongside the expansion of IVF infrastructure. The high incidence of genetic abnormalities fosters the adoption of early genetic testing, while rising infertility is linked to lifestyle factors and environmental influences, amplifying the need for IVF solutions. Preimplantation genetic testing enhances IVF success rates and reduces the number of cycles needed, becoming essential in reproductive health. Additionally, growing public awareness about genetic diseases and maternal health promotes market growth. However, challenges such as high procedure costs, ethical concerns, workforce shortages, and uncertainties in clinical outcomes could hinder market penetration going forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preimplantation Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preimplantation Genetic Testing Market Segments Analysis

Global Preimplantation Genetic Testing Market is segmented by Test Type, Technology, Category, End-User and region. Based on Test Type, the market is segmented into Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS) / Aneuploidy Screening, HLA Typing / Embryo Matching and Others. Based on Technology, the market is segmented into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Comparative Genomic Hybridization / Microarray and Single-Nucleotide Polymorphism (SNP) & AI-based Platforms. Based on Category, the market is segmented into Reagents & Consumables, Instruments / Platforms and Software & Bioinformatics Services. Based on End-User, the market is segmented into Fertility Clinics / IVF Centres, Hospitals & Assisted Reproductive Technology (ART) Centres and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preimplantation Genetic Testing Market

The global preimplantation genetic testing market is experiencing significant growth due to the surge in the number of IVF centers, fertility clinics, and specialized diagnostic laboratories worldwide, which enhances the demand for these testing services. Additionally, substantial investments aimed at improving reproductive healthcare infrastructure, particularly in developing regions, are opening new avenues for preimplantation genetic testing providers. This expansion in fertility service infrastructure is a key factor propelling the market forward, as it increases accessibility and awareness of genetic testing options, ultimately leading to a brighter outlook for the preimplantation genetic testing industry on a global scale.

Restraints in the Global Preimplantation Genetic Testing Market

The global preimplantation genetic testing market faces significant challenges due to the high costs associated with these procedures, which considerably increase the overall expenses of in vitro fertilization (IVF). This financial burden can discourage many couples, particularly those with limited financial means, from pursuing such options. The elevated costs are primarily a result of the need for advanced technology, state-of-the-art laboratory infrastructure, and specialized expertise. Additionally, the absence of reimbursement options exacerbates the issue, further limiting access for individuals in low- and middle-income regions, thus hindering wider adoption of preimplantation genetic testing.

Market Trends of the Global Preimplantation Genetic Testing Market

The Global Preimplantation Genetic Testing market is increasingly witnessing a shift towards non-invasive genetic testing approaches, driven by the rising demand for safer, minimally invasive procedures. Innovations in techniques for analyzing cell-free DNA from spent embryo culture media are transforming traditional methods by eliminating the need for embryo cell extraction, thereby minimizing potential damage to embryos. This advancement not only enhances the safety and viability of the testing process but also aligns with growing consumer preferences for less invasive medical practices. As a result, the market is poised for significant growth with the adoption of these progressive methodologies.